Treatment with Biologicals in Rheumatoid Arthritis: An Overview

por Rein, Philipp, Mueller, Ruediger B.
Publicado 2017

Rheumatoid Arthritis from Pathogenesis to Therapeutic Strategies

por Mueller, Ruediger B., Hasler, Paul
Publicado 2020

Change from subcutaneous to intravenous abatacept and back in patients with rheumatoid arthritis as simulation of a vacation: a prospective phase IV, open-label trial (A-BREAK)

por Mueller, Ruediger B., Gengenbacher, Michael, Richter, Symi, Dudler, Jean, Möller, Burkhard, von Kempis, Johannes
Publicado 2016

An assessment of the current treatment landscape for rheumatology patients in Qatar: Recognising unmet needs and moving towards solutions

por Emadi, Samar Al, Hammoudeh, Mohammed, Mounir, Mohamed, Mueller, Ruediger B., Wells, Alvin F., Sarakbi, Housam Aldeen
Publicado 2017

Clinical and radiographic course of early undifferentiated arthritis under treatment is not dependent on the number of joints with erosions at diagnosis: results from the Swiss pro...

por Mueller, Ruediger B, Kaegi, Toni, Haile, Sarah R, Schulze-Koops, Hendrik, Schiff, Michael, von Kempis, Johannes
Publicado 2018

Superiority of a Treat-to-Target Strategy over Conventional Treatment with Fixed csDMARD and Corticosteroids: A Multi-Center Randomized Controlled Trial in RA Patients with an Inad...

por Mueller, Ruediger B., Spaeth, Michael, von Restorff, Cord, Ackermann, Christoph, Schulze-Koops, Hendrik, von Kempis, Johannes
Publicado 2019

Disease activity dynamics in rheumatoid arthritis: patients’ self-assessment of disease activity via WebApp

por Walker, Ulrich A., Mueller, Ruediger B., Jaeger, Veronika K., Theiler, Robert, Forster, Adrian, Dufner, Patrick, Ganz, Fabiana, Kyburz, Diego
Publicado 2017

Effect of dose adjustments on the efficacy and safety of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of an open-label, long-term extension study (ORAL Se...

por Mueller, Ruediger B., Schulze-Koops, Hendrik, Furst, Daniel E., Cohen, Stanley B. , Kwok, Kenneth, Wang, Lisy, Killeen, Tim, von Kempis, Johannes
Publicado 2022

Site-specific resolution of enthesitis in patients with axial spondyloarthritis treated with tumor necrosis factor inhibitors

por Nissen, Michael J., Möller, Burkhard, Ciurea, Adrian, Mueller, Ruediger B., Zueger, Patrick, Schulz, Martin, Ganz, Fabiana, Scherer, Almut, Papagiannoulis, Eleftherios, Hügle, Thomas
Publicado 2021

Effectiveness, Tolerability, and Safety of Tofacitinib in Rheumatoid Arthritis: A Retrospective Analysis of Real-World Data from the St. Gallen and Aarau Cohorts

por Mueller, Ruediger B., Hasler, Caroline, Popp, Florian, Mattow, Frederik, Durmisi, Mirsada, Souza, Alexander, Hasler, Paul, Rubbert-Roth, Andrea, Schulze-Koops, Hendrik, von Kempis, Johannes
Publicado 2019

Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical care

por Riek, Myriam, Scherer, Almut, Möller, Burkhard, Ciurea, Adrian, von Mühlenen, Ines, Gabay, Cem, Kyburz, Diego, Brulhart, Laure, von Kempis, Johannes, Mueller, Ruediger B., Hasler, Paul, Strahm, Tanja, von Känel, Sabine, Zufferey, Pascal, Dudler, Jean, Finckh, Axel
Publicado 2023